In actual clinical practice, a glioma should be classified as wildtype when both R132H-IDH immunohistochemistry and subsequent IDH1/2 sequencing revel wildtype sequences at IDH1 codon 132 and IDH2 codon 1721. This evidence concerns the gene IDH2 and glioma.